Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...

Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving ...

In today’s ACT Brief, we examine how site-level data capture is becoming central to trial execution, how Merck and Mayo ...

Jonathan Andrus, co-CEO of CRIO, discusses how increased reliance on site-based technologies and eSource is strengthening ...

Mayo Clinic, for its part, described the collaboration as its first strategic partnership of this scale with a global ...

In today’s ACT Brief, we examine how SCOPE 2026 reinforced the link between speed and strategy, how AI adoption is driving ...

While there are shared principles across development programs, Barr noted that the nuances within immunology, ophthalmology, or chronic care studies can determine whether a trial succeeds or fails.

Sponsors that proactively standardized data, adopted practical AI tools, and experimented responsibly, she noted, were already seeing measurable gains in efficiency and competitiveness. Editor's note: ...

In today’s ACT Brief, we examine how predictive analytics are shaping portfolio decisions, how industry collaboration is ...

TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic ...

Zubel: In terms of analytics and AI, faster clinical data monitoring is already achievable. Predictive modeling is improving, but accuracy remains a challenge, particularly in oncology.

In today’s ACT Brief, we examine how AI is enabling continuous trial monitoring and faster site decisions, how provider ...